Previous Close | 236.00 |
Open | 236.00 |
Bid | 231.50 |
Ask | 235.50 |
Strike | 230.00 |
Expire Date | 2025-01-17 |
Day's Range | 236.00 - 236.00 |
Contract Range | N/A |
Volume | |
Open Interest | 10 |
The company entered into a buyout agreement with Eli Lilly.
(Bloomberg) -- A well-timed options trade in Point Biopharma Global Inc. stands to hand some investors upwards of $500,000 after Eli Lilly & Co.’s agreement to acquire the company sent its stock surging.Most Read from BloombergKey Taiwan Tech Firms Helping Huawei With China Chip PlantsWhy a US Recession Is Still Likely — and Coming SoonAirbnb Is Fundamentally Broken, Its CEO Says. He Plans to Fix It.Stocks, Treasuries Pummeled by Too Hot Jobs Data: Markets WrapJPMorgan’s Dimon Predicts 3.5-Day W
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.